Literature DB >> 27007855

β-Arrestin biosensors reveal a rapid, receptor-dependent activation/deactivation cycle.

Susanne Nuber1,2, Ulrike Zabel1,2, Kristina Lorenz1,3, Andreas Nuber1, Graeme Milligan4, Andrew B Tobin5, Martin J Lohse1,2,3, Carsten Hoffmann1,2.   

Abstract

(β-)Arrestins are important regulators of G-protein-coupled receptors (GPCRs). They bind to active, phosphorylated GPCRs and thereby shut off 'classical' signalling to G proteins, trigger internalization of GPCRs via interaction with the clathrin machinery and mediate signalling via 'non-classical' pathways. In addition to two visual arrestins that bind to rod and cone photoreceptors (termed arrestin1 and arrestin4), there are only two (non-visual) β-arrestin proteins (β-arrestin1 and β-arrestin2, also termed arrestin2 and arrestin3), which regulate hundreds of different (non-visual) GPCRs. Binding of these proteins to GPCRs usually requires the active form of the receptors plus their phosphorylation by G-protein-coupled receptor kinases (GRKs). The binding of receptors or their carboxy terminus as well as certain truncations induce active conformations of (β-)arrestins that have recently been solved by X-ray crystallography. Here we investigate both the interaction of β-arrestin with GPCRs, and the β-arrestin conformational changes in real time and in living human cells, using a series of fluorescence resonance energy transfer (FRET)-based β-arrestin2 biosensors. We observe receptor-specific patterns of conformational changes in β-arrestin2 that occur rapidly after the receptor-β-arrestin2 interaction. After agonist removal, these changes persist for longer than the direct receptor interaction. Our data indicate a rapid, receptor-type-specific, two-step binding and activation process between GPCRs and β-arrestins. They further indicate that β-arrestins remain active after dissociation from receptors, allowing them to remain at the cell surface and presumably signal independently. Thus, GPCRs trigger a rapid, receptor-specific activation/deactivation cycle of β-arrestins, which permits their active signalling.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27007855      PMCID: PMC5157050          DOI: 10.1038/nature17198

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  38 in total

Review 1.  Fluorescence/bioluminescence resonance energy transfer techniques to study G-protein-coupled receptor activation and signaling.

Authors:  Martin J Lohse; Susanne Nuber; Carsten Hoffmann
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

2.  A FlAsH-based FRET approach to determine G protein-coupled receptor activation in living cells.

Authors:  Carsten Hoffmann; Guido Gaietta; Moritz Bünemann; Stephen R Adams; Silke Oberdorff-Maass; Björn Behr; Jean-Pierre Vilardaga; Roger Y Tsien; Mark H Ellisman; Martin J Lohse
Journal:  Nat Methods       Date:  2005-02-17       Impact factor: 28.547

3.  The differential engagement of arrestin surface charges by the various functional forms of the receptor.

Authors:  Susan M Hanson; Vsevolod V Gurevich
Journal:  J Biol Chem       Date:  2005-12-08       Impact factor: 5.157

Review 4.  The structural basis of arrestin-mediated regulation of G-protein-coupled receptors.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Pharmacol Ther       Date:  2006-02-03       Impact factor: 12.310

5.  Arrestin interactions with G protein-coupled receptors.

Authors:  Martin J Lohse; Carsten Hoffmann
Journal:  Handb Exp Pharmacol       Date:  2014

6.  Phosphodiesterase activation by photoexcited rhodopsin is quenched when rhodopsin is phosphorylated and binds the intrinsic 48-kDa protein of rod outer segments.

Authors:  U Wilden; S W Hall; H Kühn
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

7.  The role of arrestin alpha-helix I in receptor binding.

Authors:  Sergey A Vishnivetskiy; Derek Francis; Ned Van Eps; Miyeon Kim; Susan M Hanson; Candice S Klug; Wayne L Hubbell; Vsevolod V Gurevich
Journal:  J Mol Biol       Date:  2009-10-31       Impact factor: 5.469

8.  Cell biology: Receptor signals come in waves.

Authors:  Martin J Lohse; Davide Calebiro
Journal:  Nature       Date:  2013-03-20       Impact factor: 49.962

9.  beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor.

Authors:  Sudha K Shenoy; Matthew T Drake; Christopher D Nelson; Daniel A Houtz; Kunhong Xiao; Srinivasan Madabushi; Eric Reiter; Richard T Premont; Olivier Lichtarge; Robert J Lefkowitz
Journal:  J Biol Chem       Date:  2005-11-09       Impact factor: 5.157

10.  Conformational biosensors reveal GPCR signalling from endosomes.

Authors:  Roshanak Irannejad; Jin C Tomshine; Jon R Tomshine; Michael Chevalier; Jacob P Mahoney; Jan Steyaert; Søren G F Rasmussen; Roger K Sunahara; Hana El-Samad; Bo Huang; Mark von Zastrow
Journal:  Nature       Date:  2013-03-20       Impact factor: 49.962

View more
  77 in total

Review 1.  A Biased View of μ-Opioid Receptors?

Authors:  Alexandra E Conibear; Eamonn Kelly
Journal:  Mol Pharmacol       Date:  2019-06-07       Impact factor: 4.436

2.  Revealing the Activity of Trimeric G-proteins in Live Cells with a Versatile Biosensor Design.

Authors:  Marcin Maziarz; Jong-Chan Park; Anthony Leyme; Arthur Marivin; Alberto Garcia-Lopez; Prachi P Patel; Mikel Garcia-Marcos
Journal:  Cell       Date:  2020-07-06       Impact factor: 41.582

3.  Conformational Profiling of the AT1 Angiotensin II Receptor Reflects Biased Agonism, G Protein Coupling, and Cellular Context.

Authors:  Dominic Devost; Rory Sleno; Darlaine Pétrin; Alice Zhang; Yuji Shinjo; Rakan Okde; Junken Aoki; Asuka Inoue; Terence E Hébert
Journal:  J Biol Chem       Date:  2017-02-17       Impact factor: 5.157

Review 4.  Barcoding of GPCR trafficking and signaling through the various trafficking roadmaps by compartmentalized signaling networks.

Authors:  Suleiman W Bahouth; Mohammed M Nooh
Journal:  Cell Signal       Date:  2017-04-24       Impact factor: 4.315

Review 5.  The Diverse Roles of Arrestin Scaffolds in G Protein-Coupled Receptor Signaling.

Authors:  Yuri K Peterson; Louis M Luttrell
Journal:  Pharmacol Rev       Date:  2017-07       Impact factor: 25.468

6.  Sequence-Specific Regulation of Endocytic Lifetimes Modulates Arrestin-Mediated Signaling at the µ Opioid Receptor.

Authors:  Zara Y Weinberg; Amanda S Zajac; Tiffany Phan; Daniel J Shiwarski; Manojkumar A Puthenveedu
Journal:  Mol Pharmacol       Date:  2017-02-02       Impact factor: 4.436

7.  Structures of the glucocorticoid-bound adhesion receptor GPR97-Go complex.

Authors:  Yu-Qi Ping; Chunyou Mao; Peng Xiao; Ru-Jia Zhao; Yi Jiang; Zhao Yang; Wen-Tao An; Dan-Dan Shen; Fan Yang; Huibing Zhang; Changxiu Qu; Qingya Shen; Caiping Tian; Zi-Jian Li; Shaolong Li; Guang-Yu Wang; Xiaona Tao; Xin Wen; Ya-Ni Zhong; Jing Yang; Fan Yi; Xiao Yu; H Eric Xu; Yan Zhang; Jin-Peng Sun
Journal:  Nature       Date:  2021-01-06       Impact factor: 49.962

Review 8.  β2 Adrenergic Receptor Complexes with the L-Type Ca2+ Channel CaV1.2 and AMPA-Type Glutamate Receptors: Paradigms for Pharmacological Targeting of Protein Interactions.

Authors:  Kwun Nok Mimi Man; Manuel F Navedo; Mary C Horne; Johannes W Hell
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-09-27       Impact factor: 13.820

9.  Gq activity- and β-arrestin-1 scaffolding-mediated ADGRG2/CFTR coupling are required for male fertility.

Authors:  Dao-Lai Zhang; Yu-Jing Sun; Ming-Liang Ma; Yi-Jing Wang; Hui Lin; Rui-Rui Li; Zong-Lai Liang; Yuan Gao; Zhao Yang; Dong-Fang He; Amy Lin; Hui Mo; Yu-Jing Lu; Meng-Jing Li; Wei Kong; Ka Young Chung; Fan Yi; Jian-Yuan Li; Ying-Ying Qin; Jingxin Li; Alex R B Thomsen; Alem W Kahsai; Zi-Jiang Chen; Zhi-Gang Xu; Mingyao Liu; Dali Li; Xiao Yu; Jin-Peng Sun
Journal:  Elife       Date:  2018-02-02       Impact factor: 8.140

10.  Molecular mechanism of GPCR-mediated arrestin activation.

Authors:  Naomi R Latorraca; Jason K Wang; Brian Bauer; Raphael J L Townshend; Scott A Hollingsworth; Julia E Olivieri; H Eric Xu; Martha E Sommer; Ron O Dror
Journal:  Nature       Date:  2018-05-02       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.